UK life sciences venture capital funding lags behind
At the BioTrinity Conference, experts champion government funding programmes to bridge gaps in UK venture capital financing.
Capital Raising
Saving shelved ultra-rare therapies through unorthodox funding
AdvanCell raises $112m as radiopharma buzz continues
Pan Cancer T raises funds through seed extension round
Biotech fund Curie.Bio augments reserves with $380m to boost startups
Life science SMEs “heading out of the funding winter”
BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
BIO-Europe 2023: Translational funding needed to spur pharma innovation in Europe
